Technical Analysis for GOSS - Gossamer Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.67 | -0.30% | 0.00 |
GOSS closed down 0.3 percent on Friday, April 26, 2024, on 1.34 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -0.30% | |
| Down 3 Days in a Row | Weakness | -0.30% | |
| Down 4 Days in a Row | Weakness | -0.30% | |
| Down 5 Days in a Row | Weakness | -0.30% |
| Alert | Time |
|---|---|
| Down 2 % | about 16 hours ago |
| Down 1% | about 16 hours ago |
| 60 Minute Opening Range Breakdown | about 16 hours ago |
| Possible NR7 | about 16 hours ago |
| 60 Minute Opening Range Breakout | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Disease Immunology Inflammation Millennium Pharmaceuticals
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Disease Immunology Inflammation Millennium Pharmaceuticals
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.88 |
| 52 Week Low | 0.4525 |
| Average Volume | 1,553,585 |
| 200-Day Moving Average | 0.97 |
| 50-Day Moving Average | 1.16 |
| 20-Day Moving Average | 0.91 |
| 10-Day Moving Average | 0.76 |
| Average True Range | 0.09 |
| RSI (14) | 20.63 |
| ADX | 41.15 |
| +DI | 7.43 |
| -DI | 27.94 |
| Chandelier Exit (Long, 3 ATRs) | 1.01 |
| Chandelier Exit (Short, 3 ATRs) | 0.90 |
| Upper Bollinger Bands | 1.25 |
| Lower Bollinger Band | 0.57 |
| Percent B (%b) | 0.14 |
| BandWidth | 74.62 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.12 |
| MACD Histogram | -0.0196 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.75 | ||||
| Resistance 3 (R3) | 0.76 | 0.73 | 0.74 | ||
| Resistance 2 (R2) | 0.73 | 0.71 | 0.73 | 0.73 | |
| Resistance 1 (R1) | 0.70 | 0.70 | 0.69 | 0.70 | 0.73 |
| Pivot Point | 0.68 | 0.68 | 0.67 | 0.67 | 0.68 |
| Support 1 (S1) | 0.64 | 0.66 | 0.63 | 0.64 | 0.61 |
| Support 2 (S2) | 0.62 | 0.64 | 0.62 | 0.60 | |
| Support 3 (S3) | 0.59 | 0.62 | 0.60 | ||
| Support 4 (S4) | 0.58 |
